Last reviewed · How we verify

spinal administration of articaine — Competitive Intelligence Brief

spinal administration of articaine (spinal administration of articaine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia.

phase 3 Local anesthetic (amide) Voltage-gated sodium channels Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

spinal administration of articaine (spinal administration of articaine) — Reinier de Graaf Groep. Articaine is a local anesthetic that blocks sodium channels in nerve fibers when administered into the spinal canal, preventing pain signal transmission.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
spinal administration of articaine TARGET spinal administration of articaine Reinier de Graaf Groep phase 3 Local anesthetic (amide) Voltage-gated sodium channels
Exparel TAP + multi-modal pain regimen Exparel TAP + multi-modal pain regimen Pacira Pharmaceuticals, Inc marketed Local anesthetic (liposomal formulation) Voltage-gated sodium channels
ESL ESL Bial - Portela C S.A. marketed Voltage-gated sodium channel blocker; anticonvulsant Voltage-gated sodium channels (Nav)
carbamazepine ER (Equetro) carbamazepine ER (Equetro) Massachusetts General Hospital marketed Anticonvulsant; mood stabilizer Voltage-gated sodium channels
Bupivacaine Liposomes(BL) Bupivacaine Liposomes(BL) Huazhong University of Science and Technology marketed Local anesthetic (liposomal formulation) Voltage-gated sodium channels
Suzetrigine (SUZ) Suzetrigine (SUZ) Vertex Pharmaceuticals Incorporated marketed Selective sodium channel inhibitor Voltage-gated sodium channels (Nav)
Exparel + Bupivacaine Exparel + Bupivacaine Pacira Pharmaceuticals, Inc marketed Local anesthetic (liposomal formulation) Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

  1. Poznan University of Medical Sciences · 4 drugs in this class
  2. Nantes University Hospital · 3 drugs in this class
  3. Bozyaka Training and Research Hospital · 2 drugs in this class
  4. ASST Gaetano Pini-CTO · 2 drugs in this class
  5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
  6. Chiang Mai University · 1 drug in this class
  7. Beijing Tiantan Hospital · 1 drug in this class
  8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
  9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
  10. China Medical University, China · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). spinal administration of articaine — Competitive Intelligence Brief. https://druglandscape.com/ci/spinal-administration-of-articaine. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: